ArticleJournal of thoracic disease2025
Detection of malignant lung tumors using stimulated Raman histology and convolutional neural networks.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with lung tumors often receive their histopathological diagnosis intraoperatively, based on hematoxylin and eosin-stained frozen sections. However, this approach is time and labour-intensive. Intraoperative stimulated Raman histology (SRH) may bypass traditional histopathologic processing as it leverages stimulated Raman scattering (SRS) of photons at molecules in fresh tissue samples to generate histologic images. Automated image analysis using convolutional neural networks (CNNs) could further accelerate intraoperative histopathological diagnosis. This study aimed to investigate CNN-based detection of lung cancer and the ability to distinguish between histologic subtypes, primary lung tumors, and pulmonary metastasis. Methods: A total of 459 fresh frozen tissue samples were obtained from 133 patients undergoing lung resection for intrapulmonary malignancies. SRS and SRH images were acquired, images were annotated, and three CNNs were trained and evaluated on both SRS and SRH images. Results: When distinguishing between intrapulmonary malignancy and normal lung tissue, the three different CNNs VGG19 achieved a balanced accuracy of 0.89 (0.95 on SRH images), ResNet50 achieved a balanced accuracy of 0.87 (0.89 on SRH images), and Inception-ResNet-v2 achieved a balanced accuracy of 0.91 (0.94 on SRH images). On SRS images, Inception-ResNet-v2 (0.91) showed the best results, followed by VGG19 (0.89). Compared to SRS images, the SRH images show higher balanced accuracy. Neither a distinction between primary lung cancer and metastases nor between squamous cell carcinoma and adenocarcinoma was achieved. Conclusions: The results of this study demonstrate the ability of CNNs to identify malignant tumors of the lung on SRS and SRH images. A distinction between different World Health Organization (WHO) subtypes of primary lung cancer and between primary lung cancer and metastases was inaccurate in our dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.